• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Fisetin mitigates hepatic ischemia-reperfusion injury by regulating GSK3 β/AMPK/NLRP3 inflammasome pathway

    2021-09-23 16:43:10JunLingPuZuoTinHungYunHiLuoTongMouTingTingLiZhongTngLiXuFuWeiZhongJunWu

    Jun-Ling Pu ,Zuo-Tin Hung ,Yun-Hi Luo ,Tong Mou ,Ting-Ting Li ,Zhong-Tng Li ,Xu-Fu Wei,Zhong-Jun Wu,*

    a Department of Hepatobiliary Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 40 0 016, China

    b Department of Anatomy, Basic Medical College, Chongqing Medical University, Chongqing 40 0 016, China

    Keywords:Fisetin Hepatic ischemia-reperfusion injury GSK3 β AMPK NLRP3

    ABSTRACT Background: Hepatic ischemia-reperfusion (I/R) injury (IRI) represents a crucial challenge in liver transplantation.Fisetin has anti-inflammatory,anti-aging and anti-oxidative properties.This study aimed to examine whether fisetin mitigates hepatic IRI and examine its underlying mechanisms.Methods: Sham or warm hepatic I/R operated mice were pretreated with fisetin (5,10 or 20 mg/kg).Hepatic histological assessments,TUNEL assays and serum aminotransferase measurements were performed.An in vitro hypoxia/reoxygenation (H/R) model using RAW264.7 macrophages pretreated with fisetin (2.5,5 or 10 μmol/L) was also used.Serum and cell supernatant concentrations of interleukin-1 β (IL-1 β),IL-18 and tumor necrosis factor-α (TNF-α) were determined by enzyme-linked immunosorbent assay (ELISA).Protein levels of p-GSK3 β,p-AMPK and NLR family pyrin domain-containing 3 (NLRP3)-associated proteins were detected by Western blotting.Results: Compared with the I/R group,fisetin pretreatment reduced pathological liver damage,serum aminotransferase levels,serum concentrations of IL-1 β,IL-18 and TNF-α in the murine IRI model.Fisetin also reduced the expression of NLRP3 inflammasome-associated proteins (NLRP3,cleaved caspase-1,IL-1 β and IL-18) in I/R-operated liver.The experiments in vitro showed that fisetin decreased the release of IL-1 β,IL-18 and TNF-α,and reduced the expression of NLRP3 inflammasome-associated proteins in H/R-treated RAW264.7 cells.Moreover,fisetin increased the expressions of p-GSK3 β and p-AMPK in both models,indicating that its anti-inflammatory effects were dependent on GSK3 β/AMPK signaling.The antiinflammatory effects of fisetin were partially inhibited by the AMPK specific inhibitor compound C.Conclusions: Fisetin showed protective effects against hepatic IRI,countering inflammatory responses through mediating the GSK3 β/AMPK/NLRP3 inflammasome pathway.

    Introduction

    Hepatic ischemia-reperfusion (I/R) injury (IRI) represents a crucial challenge for patients undergoing liver surgical procedures,especially for liver transplants [1] .Increased ischemia time and exacerbated hepatic IRI may cause postoperative complications including early graft dysfunction and graft rejection,threatening the survival of patients [2,3].The underlying physiopathology of I/R damage is complex,and excessive inflammatory response was considered a critical process during I/R [4,5].As an essential tissue-damage detector,the NLR family pyrin domain-containing 3(NLRP3) inflammasome is prominent for initiating and amplifying the inflammatory response.Moreover,accumulating evidence implicates the involvement of NLRP3 inflammasome in the pathogenesis of hepatic IRI [6-8].

    The NLRP3 inflammasome is activated when cellular homeostasis is disturbed,either through endogenous (tissue injury)or pathogenic (infection) signals,followed by caspase-1 autoactivation.Thereafter,caspase-1 processes precursor interleukin-1β(proIL-1β) and proIL-18 into active forms,followed with their release [9,10].With respect to relieving hepatic I/R damage,potential therapeutic targets have been identified,including the glycogen synthase kinase 3β(GSK3β) [11] .GSK3βregulates various physiological processes including metabolism,apoptosis,and immunoregulation [12] .As a constitutively active protein kinase,the enzymatic activity of GSK3βis inhibited by phosphorylation at Ser9 and enhanced by phosphorylation at Tyr216.It is noteworthy that GSK3βinhibition through Ser9 phosphorylation has been demonstrated to successfully relieve hepatic IRI [11] .In addition,GSK3βalso regulates the activity of adenosine monophosphateactivated protein kinase (AMPK),a well-known metabolic regulator [13] .AMPK was shown to alleviate hepatic IRI through inhibiting macrophage activation [14] .The recent evidence suggests that the NLRP3 inflammasome might be regulated by AMPK in macrophages [15] .Thus,this collective evidence proposes that NLRP3 inflammasome regulation occurs through the GSK3β/AMPK pathway.

    Fisetin is a plant bioflavonoid extracted from fruits,including apples,strawberries and persimmons.It was shown to have therapeutic potential in cancer,inflammatory and metabolic diseases [16] .Furthermore,several studies indicated that fisetin could mitigate myocardial IRI [17,18].Interestingly,fisetin was documented to have a regulatory effect on GSK3βand AMPK [17,19].The present study was to define the potential of fisetin to alleviate hepatic IRI,particularly its actions against GSK3β/AMPK/NLRP3 inflammasome signaling.

    Materials and methods

    Preparation of fisetin

    Fisetin (purity>98%) provided by MedChemExpress (Monmouth Junction,NJ,USA) was dissolved by DMSO (Sigma,St.Louis,MO,USA) and further diluted by saline or cell culture medium before use.

    Animals

    Male C57BL/6J mice (weighing 25-28 g) were supplied by the Experimental Animal Center of Chongqing Medical University (Chongqing,China).The animals were bred under specific pathogen-free conditions.All animal experiments were authorized by the Ethics Committee of The First Affiliated Hospital of Chongqing Medical University (2020-514).

    Surgical procedures

    Thirty C57BL/6J mice were randomized into six groups (n=5 each group):sham group,sham+FIS-20 group (sham with 20 mg/kg fisetin pretreatment),I/R group (I/R operation alone),and I/R with three concentrations of fisetin pretreatment groups (5,10 or 20 mg/kg,respectively).Mice were anesthetized with pentobarbital (40 mg/kg,Merck,Kenilworth,NJ,USA) by intraperitoneal injection.For I/R operation groups,a 70% warm hepatic I/R surgery was performed as described [20] .Briefly,the portal vein and hepatic artery were occluded by arterial clips for 1 h and then reperfused for 6 h.The sham group underwent similar procedures without clamping.For fisetin pretreatment groups,fisetin was administered intraperitoneally 0.5 h before operation.All mice were sacrificed after 6 h upon reperfusion.

    Macrophage culture

    RAW264.7 macrophages were provided by Cell Bank of the Type Culture Collection of the Chinese Academy of Sciences and cultured in Dulbecco’s Modified Eagle’s Medium (Gibco,Grand Island,NY,USA) containing 10% fetal bovine serum (HyClone,Logan,Utah,USA) at 37 °C and 5% CO2.

    Hypoxia/reoxygenation (H/R) in vitro model

    RAW264.7 macrophages were exposed to hypoxic culture conditions for 6 h (1% O2and 5% CO2) in a triple gas incubator(Thermo,Waltham,MA,USA) before storing cells to normoxia for 6 h as previously described [20] .Cells were treated with 2.5,5 or 10 μmol/L fisetin during H/R along with the AMPK inhibitor compound C (Comp.C;MedChemExpress) with the following experimental groups used:control group,FIS-10 group (10 μmol/L fisetin),H/R group,H/R+FIS-2.5 group (H/R with 2.5 μmol/L fisetin),H/R+FIS-5 group (5 μmol/L fisetin),H/R+FIS-10 group(10 μmol/L fisetin),H/R+Comp.C group (10 μmol/L compound C) and H/R+FIS-10+Comp.C group (10 μmol/L fisetin and compound C,respectively).Cell lysates and supernatants were obtained for further analysis.

    Hematoxylin and eosin (HE) staining and TUNEL assays

    Paraformaldehyde-fixed paraffin-embedded liver tissue specimens were sectioned and subjected to standard HE staining.Afterwards,the severity of hepatic pathological impairment was evaluated by the Suzuki’s injury scoring system [21] .For assessment of apoptosis,sections were stained using the TUNEL kit (Roche,Basel,Switzerland) following the manufacturer’s illustrations.

    Aminotransferase assay

    Serum samples were used to analyze the concentrations of alanine aminotransferase (ALT) and aspartate aminotransferase (AST)using special aminotransferase assay kits (Nanjing Jiancheng Bioengineering Institute,Nanjing,China) following the manufacturer’s instructions.

    Cytokines determination

    IL-1β,IL-18 and tumor necrosis factor-α(TNF-α) concentrations in serum and cell supernatants were determined by enzyme-linked immunosorbent assay (ELISA) kits (Neobioscience,Beijing,China)following the manufacturer’s instructions.

    Western blotting

    Tissue and cell lysates were prepared using the RIPA kit(Boster,Wuhan,China) [22] .Equal amounts of soluble protein(measured by BCA method) were resolved by SDS-PAGE,transferred to PVDF membranes before analysis by Western blotting using antibodies directed against p-GSK3β(Ser9,Bioss,Beijing,China),GSK3β(Proteintech,Wuhan,China),p-AMPK (Thr172,ABclonal,Wuhan,China),AMPK (Proteintech),NLRP3 (Bioss),IL-1β(Wanleibio,Shanghai,China),proIL-1β(Wanleibio),IL-18 (Proteintech),proIL-18 (Bioss),cleaved caspase-1 (Abcam,Cambridge,UK),caspase-1 (Abcam) andβ-actin (Proteintech).

    Statistical analysis

    Data analyses were performed using GraphPad Prism v8.0(GraphPad Software,San Diego,CA,USA).All data were expressed as mean ± standard deviation (SD).One-way analysis of variance(ANOVA) tests with Turkey’sposthoctests were used to identify statistical differences among multiple groups.APvalue<0.05(two-tailed) was defined as statistically significant.

    Fig.1.Fisetin improves liver function and decreases inflammatory cytokines after I/R operation in mice.n=5/group.** P < 0.01,vs.Sham;## P < 0.01,vs.I/R.

    Results

    Fisetin improves liver function and decreases inflammatory cytokines after I / R operation

    As the primary diagnostic parameters of liver function,serum ALT and AST concentrations were significantly elevated after the 70% warm hepatic I/R operation.Notably,pretreatment with increasing doses of fisetin (5,10 or 20 mg/kg) gradually reduced ALT and AST concentrations compared to those of the I/R group (Fig.1 A and B,P<0.01),suggesting that fisetin alleviated hepatic IRI.

    As shown in Fig.1 C-E,we observed significantly increases in IL-1β,IL-18 and TNF-αafter I/R surgery (P<0.01).However,fisetin pretreatment (5,10 or 20 mg/kg) gradually attenuated the increased concentrations of these cytokines compared to those of the I/R group (P<0.01).

    Fisetin decreases the severity of histopathological changes in the I/R model

    Examination of liver sections from the sham group revealed liver lobule structures arranged in an orderly manner,the hepatic cords were clear and there was almost no hepatic injury or necrosis (Fig.2 A).Similar findings were observed in the sham+FIS-20 group,indicating that fisetin had no impact on the normal liver condition.In contrast,representative pathological changes including coagulation necrosis,severe architectural abnormalities,sinusoid congestion and vacuolization were found after I/R operation.Instructively,fisetin pretreatment (5,10 or 20 mg/kg) significantly reduced these hepatic pathological changes.These findings were confirmed after assessing liver sections using Suzuki’s scores(Fig.2 C).

    Fisetin attenuates hepatocyte apoptosis

    Consistent with the results of HE staining,the sham and the sham+FIS-20 groups had few TUNEL positive cells which dramatically increased after I/R operation (Fig.2 B).However,compared to the I/R group,fisetin pretreatment (5,10 or 20 mg/kg) reduced the number of TUNEL positive cells in a dose-dependent manner(Fig.2 B and D,P<0.01).

    Fisetin regulates the GSK3 β/AMPK/NLRP3 inflammasome pathway in the I / R model

    After the I/R procedure,liver tissues exhibited significant increase in the expression of NLRP3,cleaved caspase-1,IL-1βand IL-18 compared to those of the sham group,while p-GSK3β(Ser9)and p-AMPK (Thr172) protein expressions were decreased (Fig.3,P<0.01).However,fisetin pretreatment (5,10 or 20 mg/kg) gradually diminished the activation of NLRP3 inflammasome-associated proteins along with the elevated levels of p-GSK3β(Ser9) and p-AMPK (Thr172) (Fig.3,P<0.05).

    Fisetin mitigates H/R-induced inflammation via the GSK3 β/AMPK/NLRP3 inflammasome pathway in vitro

    Notably,we observed significantly elevated IL-1β,IL-18 and TNF-αproduction in cell supernatants after exposure to H/R conditions (Fig.4 A-C,P<0.01).Remarkably,fisetin treatment (2.5,5 or 10 μmol/L) gradually diminished the concentrations of these cytokines (Fig.4 A-C,P<0.05).

    Indeed,H/R exposure resulted in significant elevations in the protein levels of NLRP3,cleaved caspase-1,IL-1βand IL-18,while the expressions of p-GSK3β(Ser9) and p-AMPK (Thr172) were diminished (Fig.4 D-J,P<0.01).Treatment with fisetin (2.5,5 or 10 μmol/L) gradually diminished activation of the NLRP3 inflammasome as indicated by inhibition of the increased levels of NLRP3,cleaved caspase-1,IL-1βand IL-18,and enhancement of p-GSK3β(Ser9) and p-AMPK (Thr172) expression (Fig.4 D,P<0.05).

    Fig.2.Fisetin attenuates hepatic histopathological changes and hepatocyte apoptosis after I/R operation in mice.A and C:Representative HE liver sections (original magnification × 200) and Suzuki’s score results of the different treatment groups;B and D:representative TUNEL staining of liver sections (original magnification × 400) and estimation of TUNEL positive cell numbers.n=5/group.** P < 0.01,vs.Sham;## P < 0.01,vs.I/R.

    Fig.3.Fisetin regulates GSK3 β/AMPK/NLRP3 inflammasome proteins in the liver I/R model.A:Representative Western blotting of p-GSK3 β (Ser9),p-AMPK (Thr172) and NLRP3 inflammasome-associated proteins in mouse liver tissues among the treatment groups.B-G:Quantitative analysis of all samples from A .n=5/group.** P < 0.01,vs.Sham;# P < 0.05,## P < 0.01,vs.I/R.

    Protective effects of fisetin are attenuated after inhibiting AMPK

    Compared to the H/R+FIS-10 (H/R+10 μmol/L fisetin) group,compound C significantly elevated the inflammatory cytokines(Fig.5 A-C,P<0.01).Moreover,Western blotting analysis indicated that compared with the H/R+FIS-10 group,compound C treatment (H/R+FIS-10+Comp.C group) significantly boosted the expression of NLRP3,cleaved caspase-1,IL-1βand IL-18,and reduced the p-AMPK (Thr172) expression (Fig.5 D-J,P<0.05).However,compound C treatment did not entirely block the regulation effect of fisetin on NLRP3 inflammasome.Interestingly,there was no significant difference in the expression of p-GSK3β(Ser9) between the two groups (Fig.5 D and E,P>0.05),suggesting that GSK3β(Ser9) phosphorylation was not regulated by AMPK in this scenario.

    Discussion

    As an inevitable obstacle in liver transplant operations,hepatic IRI has attracted considerable attention.As is commonly known,a longer ischemia time implies a higher risk of postoperative complications and worse prognosis [23] .Our previous studies indicated that inhibiting inflammatory reactions by targeting proinflammatory molecules may mitigate hepatic IRI [20,24].Thus,pharmacological interventions targeting specific molecules may contribute to the development of hepatic IRI treatments.Herein,we verified that fisetin improved liver function,decreased inflammatory cytokines and attenuated hepatic histopathological changesinvivo,as well as suppressing inflammatory actionsinvitro.Moreover,we link the protective effects of fisetin with regulation of the GSK3β/AMPK/NLRP3 inflammasome pathway.Our findings may provide some support for the clinical treatment of hepatic IRI.

    Fig.4.Fisetin inhibits inflammation in H/R-exposed macrophages by regulating the GSK3 β/AMPK/NLRP3 inflammasome pathway.A-C:Production of IL-1 β,IL-18 and TNF-α in RAW264.7 macrophages was measured by ELISA in the indicated treatment groups;D-J:relative expression of p-GSK3 β (Ser9),p-AMPK (Thr172) and NLRP3 inflammasome-associated proteins in the cells from A .** P < 0.01,vs.Control;# P < 0.05,## P < 0.01,vs.H/R.

    The most salient finding of our study involved the proved benefit of fisetin in relieving hepatic IRI by suppressing inflammatory reactions.This is consistent with previous studies which found that fisetin could alleviate I/R damage in other organs albeit through alternative mechanisms.Garg et al.[18] reported that fisetin reduced apoptosis,oxidative stress,and inflammation in myocardial infarction model by modulating PPAR-γas well as the NF-κB pathway.Zhang and Cui [25] also demonstrated that fisetin alleviated cerebral IRI by suppressing the NF-κB activity via inflammatory and antioxidant pathways.Besides,fisetin was reported to have protective effects in liver diseases.For instance,fisetin mitigated nonalcoholic fatty liver disease by suppressing the TNF-α/RIPK3 pathway mediated inflammation [26] .Our study now implicates the NLRP3 inflammasome as a critical target of fisetin in liver,and together with these prior studies highlights fisetin as a candidate for treating hepatic inflammation induced by different diseases.

    Fig.5.Inhibition of AMPK by compound C (10 μmol/L) partially alleviates the anti-inflammatory ability of fisetin in vitro .A-C:RAW264.7 macrophages were treated as indicated (FIS-10;10 μmol/L),and production of IL-1 β,IL-18 and TNF-α was measured by ELISA;D-J:relative expression of p-GSK3 β (Ser9),p-AMPK (Thr172) and NLRP3 inflammasome-associated proteins in the cells from A .* P < 0.05,** P < 0.01,NS P > 0.05.

    Much literature involving hepatic IRI emphasizes the significance of the NLRP3 inflammasome,especially its critical role in maturation and release of detrimental cytokines [9,10,27].As expected,we observed the elevated expression of NLRP3 inflammasome-associated proteins in bothinvivoandinvitromodels,which coincided with the enhanced production of IL-1βand IL-18.Moreover,we found that fisetin suppressed the activation of the NLRP3 inflammasome and concomitant release of downstream inflammatory cytokines in hepatic IRI.Consistently,albeit in the context of a diabetic nephropathy model,it was found that fisetin supplementation reduced NLRP3 expression in high fat diet-fed mice [28] .

    We also observed that GSK3βactivity was increased by I/R operation,manifested by decreased inhibitory phosphorylation expression of GSK3βat Ser9.Similar to previous reports,fisetin treatment suppressed GSK3βactivity through increasing p-GSK3β(Ser9) expression [17,29].GSK3βis documented to control glucose metabolism and inflammatory reaction [30,31],and may exert immune-regulatory effects by direct control of proinflammatory molecules,or by altering the cellular metabolism of immune cells to influence their activation or differentiation [11,32].In macrophages,toxins increase GSK3βactivity and activate NLRP3 inflammasome,while GSK3βinhibitors can suppress these effects [33] .Besides,inhibiting GSK3βmay protect against hepatic IRI by regulating antioxidant response and mitochondrial permeability transition [34] .Moreover,GSK3βinhibition contributes to elevated CREB activity and IL-10 production,as well as diminished NF-κB activity,which together can minimize inflammation and liver damage [11,35].

    As a central regulator of cellular energy metabolism,activation of AMPK exerts anti-inflammatory effects in various inflammatoryrelated diseases [36-38].Notably,Qing et al.[39] showed that activating AMPK could suppress the NLRP3 inflammasome by boosting M2 macrophage polarization via mTOR.Wang et al.[40] also showed that suppressing AMPK/mTOR-mediated autophagy activates the NLRP3 inflammasome in Kupffer cells.Of relevance,fisetin was reported to activate AMPK/mTOR signaling in pancreatic cancer cells [41] .In this study,we confirmed that fisetin suppressed NLRP3 inflammasome through AMPK signaling in liver tissue and murine macrophages.Interestingly,the activation of AMPK in macrophages was documented to be regulated by GSK3β[11] .On the contrary,AMPK was also reported to regulate the activity of GSK3βin macrophages [42] .However,we observed that pharmacological inhibition of AMPK did not influence the inhibitory effects of fisetin on GSK3β,nor did it entirely reverse the effects of fisetin on the NLRP3 inflammasome.While our data firmly invoke a role for the GSK3β/AMPK pathway in the fisetin-mediated regulation of the NLRP3 inflammasome,the latter finding suggests that GSK3βinhibition is at least partially uncoupled from AMPK.This further suggests that other pathways must be involved.

    Finally,we must acknowledge the limitations of our study.The pathophysiological process of IRI is complex and cannot be explained by inflammation alone.Moreover,the mouse model used a standardized I/R time and therefore more experiments are required to determine the extent of benefit provided by fisetin under different ischemia time that produce different degrees of IRI.Furthermore,there are other properties of fisetin that we have not considered in our analysis including antioxidant activity.

    In summary,we validated that fisetin protects the liver against IRI.Additionally,fisetin suppressed GSK3β,accompanied by AMPK activation,leading to NLRP3 inflammasome suppression and diminished pro-inflammatory cytokines productions.This body of work suggests fisetin intervention as a new strategy to treat hepatic IRI.

    Acknowledgments

    None.

    CRediTauthorshipcontributionstatement

    Jun-LiangPu:Data curation,Formal analysis,Writing -original draft.Zuo-TianHuang:Data curation,Formal analysis,Writing -original draft.Yun-HaiLuo:Data curation,Software,Writing-review &editing.TongMou:Data curation,Software,Writing -review &editing.Ting-TingLi:Data curation,Methodology,Writing -review &editing.Zhong-TangLi:Data curation,Methodology,Writing -review &editing.Xu-FuWei:Writing -review &editing.Zhong-JunWu:Conceptualization,Funding acquisition,Supervision,Writing -review &editing.

    Funding

    This study was supported by grants from the National Natural Science Foundation of China (81672959,81873592 and 81703063),the Science and Technology Commission Foundation of Chongqing,China (cstc2019jscx-gksbX0005),the Natural Science Foundation of Chongqing,China (cstc2018jscx-msybX0133) and the graduate tutor team construction project of Chongqing Municipal Education Commission Foundation,China (dstd201801).

    Ethicalapproval

    This study was approved by the Ethics Committee of The First Affiliated Hospital of Chongqing Medical University (2020-514).

    Competinginterest

    No benefits in any form have been received or will be received from a commercial party related directly or indirectly to the subject of this article.

    免费电影在线观看免费观看| 欧美成人免费av一区二区三区| 看免费av毛片| 久久婷婷成人综合色麻豆| 国产又色又爽无遮挡免费看| 免费人成视频x8x8入口观看| 午夜成年电影在线免费观看| 国产精品98久久久久久宅男小说| 亚洲成人中文字幕在线播放| 国产亚洲欧美在线一区二区| 欧美日韩福利视频一区二区| 99国产精品99久久久久| 国产三级中文精品| 免费看美女性在线毛片视频| 久久久久性生活片| 一级毛片精品| 神马国产精品三级电影在线观看 | 国产激情偷乱视频一区二区| 亚洲全国av大片| 亚洲精品美女久久久久99蜜臀| www.www免费av| 法律面前人人平等表现在哪些方面| 99国产精品一区二区三区| 亚洲精品一区av在线观看| 色综合站精品国产| av片东京热男人的天堂| 亚洲av片天天在线观看| 2021天堂中文幕一二区在线观| 久久久水蜜桃国产精品网| 禁无遮挡网站| 一级毛片精品| 女人高潮潮喷娇喘18禁视频| 欧美日韩乱码在线| 欧美黄色淫秽网站| 亚洲午夜精品一区,二区,三区| 人人妻人人澡欧美一区二区| 免费看美女性在线毛片视频| 亚洲av电影不卡..在线观看| 黄色成人免费大全| 美女黄网站色视频| 成人av在线播放网站| 高潮久久久久久久久久久不卡| 亚洲中文字幕日韩| 五月玫瑰六月丁香| bbb黄色大片| 黄色毛片三级朝国网站| 韩国av一区二区三区四区| 免费在线观看影片大全网站| 久久精品综合一区二区三区| bbb黄色大片| 波多野结衣巨乳人妻| 18禁观看日本| videosex国产| 亚洲人成伊人成综合网2020| 欧美高清成人免费视频www| 久久久久久九九精品二区国产 | 欧美乱码精品一区二区三区| 五月伊人婷婷丁香| 欧美成人一区二区免费高清观看 | 无限看片的www在线观看| 国产亚洲精品第一综合不卡| 国产成人精品无人区| 久久久久国产一级毛片高清牌| 两性午夜刺激爽爽歪歪视频在线观看 | 亚洲人成77777在线视频| 一级作爱视频免费观看| 韩国av一区二区三区四区| 神马国产精品三级电影在线观看 | 国产精品乱码一区二三区的特点| 国产主播在线观看一区二区| a在线观看视频网站| 在线播放国产精品三级| 三级男女做爰猛烈吃奶摸视频| 亚洲真实伦在线观看| 亚洲精品久久成人aⅴ小说| 免费看美女性在线毛片视频| 久久香蕉激情| 99久久99久久久精品蜜桃| av中文乱码字幕在线| av在线天堂中文字幕| 久久久久久亚洲精品国产蜜桃av| 精品福利观看| 国产免费av片在线观看野外av| 欧美成人一区二区免费高清观看 | 麻豆成人av在线观看| 久久这里只有精品中国| tocl精华| 搡老熟女国产l中国老女人| 成人三级黄色视频| 日韩大码丰满熟妇| 一级毛片高清免费大全| 18禁黄网站禁片免费观看直播| 国产成人精品久久二区二区91| 熟女少妇亚洲综合色aaa.| 777久久人妻少妇嫩草av网站| 少妇被粗大的猛进出69影院| 国产熟女午夜一区二区三区| 日日摸夜夜添夜夜添小说| 日韩欧美 国产精品| 国产黄a三级三级三级人| 国产麻豆成人av免费视频| 亚洲午夜理论影院| 亚洲美女视频黄频| av福利片在线| 在线十欧美十亚洲十日本专区| 日韩 欧美 亚洲 中文字幕| 国产精品 国内视频| 国产高清videossex| 夜夜看夜夜爽夜夜摸| АⅤ资源中文在线天堂| 亚洲第一欧美日韩一区二区三区| 中文亚洲av片在线观看爽| www.999成人在线观看| av福利片在线| 日韩精品中文字幕看吧| 亚洲熟妇中文字幕五十中出| 亚洲成a人片在线一区二区| 欧美日韩瑟瑟在线播放| 中文字幕人妻丝袜一区二区| 国产69精品久久久久777片 | 91麻豆精品激情在线观看国产| 国产亚洲av嫩草精品影院| 久久人妻av系列| 精品国产亚洲在线| 国产亚洲欧美在线一区二区| 蜜桃久久精品国产亚洲av| 在线观看免费视频日本深夜| 天堂√8在线中文| x7x7x7水蜜桃| 老司机深夜福利视频在线观看| 欧美黑人精品巨大| 亚洲成人久久爱视频| 女人爽到高潮嗷嗷叫在线视频| 国产精品久久久av美女十八| 成年人黄色毛片网站| 久久 成人 亚洲| 久久久国产欧美日韩av| 久久亚洲真实| 99国产精品99久久久久| 99re在线观看精品视频| 制服诱惑二区| 99久久99久久久精品蜜桃| 中文字幕人成人乱码亚洲影| 成年人黄色毛片网站| 人人妻人人看人人澡| 亚洲国产精品999在线| 母亲3免费完整高清在线观看| 欧美久久黑人一区二区| 无遮挡黄片免费观看| 日本 欧美在线| 50天的宝宝边吃奶边哭怎么回事| 国产精品久久久久久亚洲av鲁大| 成人午夜高清在线视频| 久久热在线av| 成人三级黄色视频| 国产欧美日韩一区二区精品| 成人高潮视频无遮挡免费网站| 成人亚洲精品av一区二区| 国产视频一区二区在线看| 久久精品影院6| 桃色一区二区三区在线观看| 日本黄色视频三级网站网址| 午夜亚洲福利在线播放| 一级毛片女人18水好多| 日本 av在线| 国产av又大| 亚洲av成人一区二区三| 久久精品aⅴ一区二区三区四区| 久久午夜亚洲精品久久| 亚洲一区中文字幕在线| 长腿黑丝高跟| 色尼玛亚洲综合影院| 老司机靠b影院| 91av网站免费观看| 脱女人内裤的视频| 久久精品国产亚洲av香蕉五月| 亚洲色图 男人天堂 中文字幕| 亚洲午夜理论影院| 中文字幕人妻丝袜一区二区| 欧美日韩亚洲国产一区二区在线观看| 国产精品综合久久久久久久免费| a级毛片在线看网站| 99精品在免费线老司机午夜| 草草在线视频免费看| 国产熟女午夜一区二区三区| a级毛片在线看网站| 精品一区二区三区av网在线观看| 男人舔女人下体高潮全视频| 日韩有码中文字幕| 成人国产综合亚洲| 精品久久久久久久毛片微露脸| 婷婷丁香在线五月| 神马国产精品三级电影在线观看 | 少妇粗大呻吟视频| 欧美黑人巨大hd| 免费观看精品视频网站| 久久精品国产亚洲av香蕉五月| 亚洲人成电影免费在线| 女同久久另类99精品国产91| 一夜夜www| 国产精品一区二区免费欧美| 精品人妻1区二区| 精品久久久久久久末码| 亚洲专区字幕在线| 国产亚洲欧美在线一区二区| 久久热在线av| 久久亚洲精品不卡| 久久久久久亚洲精品国产蜜桃av| 国产精品综合久久久久久久免费| 一边摸一边抽搐一进一小说| 一区二区三区国产精品乱码| 男女床上黄色一级片免费看| 国内久久婷婷六月综合欲色啪| 亚洲 国产 在线| 免费搜索国产男女视频| 国产伦在线观看视频一区| 国产精品一及| 色av中文字幕| 亚洲精品一区av在线观看| a在线观看视频网站| 国产伦在线观看视频一区| 亚洲精品色激情综合| 老司机午夜福利在线观看视频| 动漫黄色视频在线观看| 欧美黑人巨大hd| 亚洲av成人一区二区三| 九色成人免费人妻av| 成人亚洲精品av一区二区| 久久久久久九九精品二区国产 | 久久婷婷成人综合色麻豆| 久久精品国产亚洲av高清一级| 中文字幕久久专区| 午夜免费观看网址| 美女扒开内裤让男人捅视频| 国产三级在线视频| 在线观看日韩欧美| 亚洲精品在线美女| 午夜福利在线观看吧| 韩国av一区二区三区四区| 在线免费观看的www视频| 欧美中文日本在线观看视频| www.自偷自拍.com| 国产欧美日韩一区二区精品| 一边摸一边做爽爽视频免费| 欧美zozozo另类| 真人做人爱边吃奶动态| 午夜免费观看网址| √禁漫天堂资源中文www| 日本五十路高清| 久久性视频一级片| 女同久久另类99精品国产91| а√天堂www在线а√下载| 窝窝影院91人妻| 黄色女人牲交| 成人国语在线视频| 欧美又色又爽又黄视频| 日韩有码中文字幕| 三级国产精品欧美在线观看 | 亚洲男人的天堂狠狠| 日韩精品青青久久久久久| 99riav亚洲国产免费| 99国产精品一区二区三区| 亚洲精品粉嫩美女一区| 91老司机精品| 18禁国产床啪视频网站| svipshipincom国产片| 国产男靠女视频免费网站| 久久午夜亚洲精品久久| 国产亚洲精品久久久久久毛片| 91av网站免费观看| 亚洲国产日韩欧美精品在线观看 | 欧美黑人精品巨大| 精品日产1卡2卡| 好男人电影高清在线观看| 久久久久国内视频| 岛国在线观看网站| 免费av毛片视频| 欧美人与性动交α欧美精品济南到| 黄片大片在线免费观看| 午夜福利视频1000在线观看| 精品久久久久久久久久免费视频| 色老头精品视频在线观看| 久久久久免费精品人妻一区二区| 少妇被粗大的猛进出69影院| 热99re8久久精品国产| 三级男女做爰猛烈吃奶摸视频| 天天添夜夜摸| 美女扒开内裤让男人捅视频| 老司机靠b影院| 日本a在线网址| 亚洲欧洲精品一区二区精品久久久| 国产一级毛片七仙女欲春2| 国产亚洲欧美在线一区二区| 狂野欧美激情性xxxx| 久热爱精品视频在线9| 久久精品影院6| 欧美3d第一页| 久久国产精品影院| 国产黄a三级三级三级人| 女人被狂操c到高潮| 麻豆成人av在线观看| 亚洲中文av在线| 91麻豆av在线| 亚洲 欧美 日韩 在线 免费| 午夜福利免费观看在线| 亚洲精品国产一区二区精华液| 久久久久久免费高清国产稀缺| 嫩草影院精品99| 欧美大码av| 男人舔女人的私密视频| 国产精品九九99| 欧美午夜高清在线| 国产真实乱freesex| 中文资源天堂在线| 亚洲片人在线观看| 真人一进一出gif抽搐免费| 精品国内亚洲2022精品成人| 999精品在线视频| 男女之事视频高清在线观看| 九色国产91popny在线| 亚洲欧美日韩无卡精品| 男女之事视频高清在线观看| 久久天堂一区二区三区四区| 91国产中文字幕| 日本一本二区三区精品| 2021天堂中文幕一二区在线观| 亚洲一码二码三码区别大吗| 国产激情久久老熟女| 国产亚洲精品久久久久久毛片| 长腿黑丝高跟| 婷婷丁香在线五月| 黄色成人免费大全| 女生性感内裤真人,穿戴方法视频| 亚洲avbb在线观看| 在线观看66精品国产| 亚洲国产看品久久| 国产三级中文精品| 国产三级黄色录像| 可以免费在线观看a视频的电影网站| 亚洲欧美日韩高清在线视频| 色哟哟哟哟哟哟| 欧美性猛交╳xxx乱大交人| 国产69精品久久久久777片 | 欧美日韩亚洲国产一区二区在线观看| 欧美精品亚洲一区二区| 欧美黑人欧美精品刺激| 无人区码免费观看不卡| 熟妇人妻久久中文字幕3abv| 亚洲欧美日韩无卡精品| 麻豆成人午夜福利视频| 日韩精品中文字幕看吧| 长腿黑丝高跟| 91麻豆av在线| 亚洲成人免费电影在线观看| a级毛片a级免费在线| 法律面前人人平等表现在哪些方面| 亚洲成人久久性| 岛国在线免费视频观看| 国产精品久久电影中文字幕| 日韩精品青青久久久久久| 在线观看免费午夜福利视频| 97碰自拍视频| 欧美3d第一页| 午夜福利欧美成人| 亚洲第一电影网av| 99热只有精品国产| 成人一区二区视频在线观看| 亚洲av日韩精品久久久久久密| 麻豆一二三区av精品| 国产三级黄色录像| 中文资源天堂在线| 国产高清有码在线观看视频 | 亚洲av日韩精品久久久久久密| 国产激情偷乱视频一区二区| 成在线人永久免费视频| 免费在线观看视频国产中文字幕亚洲| 久久精品国产亚洲av高清一级| 757午夜福利合集在线观看| av视频在线观看入口| 国产精品一区二区三区四区免费观看 | 久久久国产欧美日韩av| 欧美极品一区二区三区四区| 久久精品国产亚洲av香蕉五月| svipshipincom国产片| 色综合亚洲欧美另类图片| 国产高清videossex| 国产精品免费一区二区三区在线| 免费在线观看日本一区| 亚洲av电影在线进入| 久久精品国产综合久久久| 久久久国产精品麻豆| 日韩欧美在线乱码| 精品国产乱码久久久久久男人| 欧美绝顶高潮抽搐喷水| 欧美黑人巨大hd| 日本成人三级电影网站| 嫁个100分男人电影在线观看| 一区二区三区激情视频| 成人av在线播放网站| 嫩草影视91久久| 很黄的视频免费| 2021天堂中文幕一二区在线观| 狂野欧美激情性xxxx| av在线播放免费不卡| 欧美中文综合在线视频| 亚洲成人国产一区在线观看| 窝窝影院91人妻| 90打野战视频偷拍视频| 欧美 亚洲 国产 日韩一| 日本a在线网址| 老司机在亚洲福利影院| 毛片女人毛片| 此物有八面人人有两片| 91麻豆av在线| 亚洲成人国产一区在线观看| 成人欧美大片| 在线观看美女被高潮喷水网站 | 我要搜黄色片| 欧美精品亚洲一区二区| 午夜精品在线福利| 久久久久久人人人人人| xxxwww97欧美| 久久精品夜夜夜夜夜久久蜜豆 | 日韩精品免费视频一区二区三区| 级片在线观看| 床上黄色一级片| 黑人操中国人逼视频| 亚洲七黄色美女视频| 一二三四在线观看免费中文在| 高清毛片免费观看视频网站| 精品国产超薄肉色丝袜足j| 精品熟女少妇八av免费久了| 亚洲成人精品中文字幕电影| 色尼玛亚洲综合影院| 亚洲男人天堂网一区| 可以在线观看毛片的网站| 国产一区二区三区在线臀色熟女| 久久精品亚洲精品国产色婷小说| 色精品久久人妻99蜜桃| 99久久久亚洲精品蜜臀av| 免费在线观看成人毛片| 欧美久久黑人一区二区| 欧美黑人欧美精品刺激| 99久久99久久久精品蜜桃| 亚洲七黄色美女视频| 在线观看免费视频日本深夜| 可以在线观看的亚洲视频| 97碰自拍视频| 欧美日韩亚洲国产一区二区在线观看| 亚洲av美国av| 在线国产一区二区在线| 人成视频在线观看免费观看| 国产一级毛片七仙女欲春2| 无人区码免费观看不卡| 亚洲国产看品久久| 久久久精品大字幕| 亚洲九九香蕉| 婷婷精品国产亚洲av| 亚洲成av人片免费观看| 99国产极品粉嫩在线观看| 亚洲欧美精品综合久久99| 久久精品国产清高在天天线| 国产1区2区3区精品| 免费观看人在逋| 久热爱精品视频在线9| 国产熟女午夜一区二区三区| 亚洲欧美日韩无卡精品| 中文在线观看免费www的网站 | 欧美激情久久久久久爽电影| 两性夫妻黄色片| 亚洲 国产 在线| 国产v大片淫在线免费观看| 国产精品久久久久久精品电影| 黑人欧美特级aaaaaa片| 亚洲av电影在线进入| 国产精品国产高清国产av| 久久性视频一级片| 最好的美女福利视频网| 久久久久精品国产欧美久久久| 99在线人妻在线中文字幕| 国产成+人综合+亚洲专区| 午夜福利在线观看吧| 日本免费一区二区三区高清不卡| 可以免费在线观看a视频的电影网站| 国产精品久久久久久精品电影| 日日摸夜夜添夜夜添小说| 18禁美女被吸乳视频| 欧美成人午夜精品| 老司机午夜十八禁免费视频| 国产免费av片在线观看野外av| 成人欧美大片| 大型av网站在线播放| 欧美日韩黄片免| 久久久久久亚洲精品国产蜜桃av| 国产私拍福利视频在线观看| 亚洲国产欧美网| 夜夜爽天天搞| 国产爱豆传媒在线观看 | 天堂动漫精品| 久久精品亚洲精品国产色婷小说| 久久久久九九精品影院| 国产男靠女视频免费网站| 丰满人妻熟妇乱又伦精品不卡| 久久久水蜜桃国产精品网| 日韩国内少妇激情av| 久久性视频一级片| 村上凉子中文字幕在线| 两个人看的免费小视频| 我要搜黄色片| 精品一区二区三区视频在线观看免费| 国产97色在线日韩免费| 黄片小视频在线播放| 91在线观看av| 国产成人影院久久av| 国产三级中文精品| 丰满人妻熟妇乱又伦精品不卡| 亚洲中文av在线| 白带黄色成豆腐渣| 亚洲人与动物交配视频| 久久精品aⅴ一区二区三区四区| 亚洲精品av麻豆狂野| 69av精品久久久久久| 亚洲一区二区三区色噜噜| 久久久国产成人精品二区| 岛国视频午夜一区免费看| 中文资源天堂在线| 亚洲五月婷婷丁香| 天天躁狠狠躁夜夜躁狠狠躁| 国语自产精品视频在线第100页| 好男人在线观看高清免费视频| 日韩欧美精品v在线| 男女那种视频在线观看| 国产黄色小视频在线观看| 精品国产亚洲在线| 老司机午夜福利在线观看视频| 99精品欧美一区二区三区四区| 特级一级黄色大片| 1024手机看黄色片| 五月伊人婷婷丁香| 窝窝影院91人妻| 亚洲黑人精品在线| 日韩精品青青久久久久久| 在线播放国产精品三级| 黄色视频,在线免费观看| 亚洲人成网站在线播放欧美日韩| aaaaa片日本免费| 国产精品,欧美在线| 女人爽到高潮嗷嗷叫在线视频| 男人的好看免费观看在线视频 | 九色国产91popny在线| 我要搜黄色片| 老司机靠b影院| 欧美另类亚洲清纯唯美| 亚洲国产欧美人成| 一二三四在线观看免费中文在| 国内精品久久久久久久电影| 国产精品免费一区二区三区在线| 特级一级黄色大片| 欧美人与性动交α欧美精品济南到| 亚洲国产看品久久| 精品高清国产在线一区| 国产成人影院久久av| 久久国产乱子伦精品免费另类| 精品久久久久久久久久免费视频| 国产高清有码在线观看视频 | 给我免费播放毛片高清在线观看| 国产男靠女视频免费网站| 两个人看的免费小视频| av视频在线观看入口| 男人舔女人的私密视频| 亚洲欧洲精品一区二区精品久久久| 俄罗斯特黄特色一大片| 国产一区二区三区视频了| 久久久久久亚洲精品国产蜜桃av| 国产高清视频在线观看网站| 婷婷亚洲欧美| x7x7x7水蜜桃| 国产成年人精品一区二区| 成人高潮视频无遮挡免费网站| 日本一区二区免费在线视频| 久久精品国产清高在天天线| 免费在线观看视频国产中文字幕亚洲| 99精品久久久久人妻精品| 久久这里只有精品中国| 欧美乱码精品一区二区三区| 成年人黄色毛片网站| 一a级毛片在线观看| 亚洲中文日韩欧美视频| 午夜福利视频1000在线观看| www日本黄色视频网| 一区二区三区国产精品乱码| 桃红色精品国产亚洲av| 中文字幕人成人乱码亚洲影| 午夜日韩欧美国产| 欧美成狂野欧美在线观看| 一区福利在线观看| 搡老熟女国产l中国老女人| 欧美色视频一区免费| 久久精品国产亚洲av香蕉五月| 一本综合久久免费| 亚洲人成电影免费在线| 国产精品一及| 岛国在线观看网站| 久久久久性生活片| 长腿黑丝高跟| 又紧又爽又黄一区二区| 久久久国产成人精品二区| 亚洲中文av在线| 一区二区三区激情视频| 精品久久久久久成人av| 久久中文字幕人妻熟女| 久久久久久人人人人人| 中文在线观看免费www的网站 | 久久婷婷成人综合色麻豆| 国产精品永久免费网站|